Health & Fitness
Health and Fitness
Health and Fitness
Wed, September 15, 2010
Tue, September 14, 2010
Celera to Webcast Its Presentation at the UBS Global Life Sciences Conference
ALAMEDA, Calif.--([ BUSINESS WIRE ])--Celera Corporation (NASDAQ:CRA) announced today that it will webcast its presentation at the UBS Global Life Sciences Conference on Tuesday, September 21, 2010. The live webcast is scheduled to begin at 2:30 pm ET when Kathy Ordoez, Chief Executive Officer of Celera, will provide an overview of the Companya™s business.
Interested parties may access the live webcast and replay by visiting the Media and Investors section of the Celera website at [ www.celera.com ]. It is suggested that participants access the webcast 15 minutes before the start of the live broadcast. The webcast replay will be archived on the Presentations page of the Media and Investors section of the website.
About Celera
Celera is a healthcare business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and improve patient management. Celera also commercializes a wide range of molecular diagnostic products through Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Celera Corporation, including reports and other information filed by the Company with the Securities and Exchange Commission, is available at [ http://www.celera.com ].
Copyright© 2010. Celera Corporation. All Rights Reserved. Celera is a registered trademark of Celera Corporation or its subsidiaries in the U. S. and/or certain other countries.
